Evidence map›Paper›PMID 24668334›Full record

ArticleThe oncologist2014

Cervical cancer-related knowledge, attitudes, and practices of health professionals working in brazil's network of primary care units.

Analía Romina Stormo, Lenildo de Moura, Mona Saraiya

Abstract read
In one paragraph

Article in The oncologist, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Dominican Provider Practices for Cervical Cancer Screening in Santo Domingo and Monte Plata Provinces.Journal of cancer education : the official journal of the American Association for Cancer Education · 2021
    Article
  8. Functioning in Women with Cervical Cancer in Brazil: the Perspective of Experts.Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia · 2018
    Article
  9. Article
  10. Article
  11. Article
  12. Predictive Capability of HPV and Pap Tests in Screening for Cervical Cancer over a Three-Year Follow-up.Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia · 2016
    Article
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Analía Romina StormoDivision of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, Georgia, USA; Organização Pan-Americana da Saúde/Organização Mundial da Saúde (OPAS/OMS), Brasilia, Brasil.
Lenildo de Moura
Mona Saraiya

Funding

HPDPRC SIP 13-66U48DP001903 · DP · SAINT LOUIS UNIVERSITY · PI BAKER, ELIZABETH A · 2009 to 2013
$7.3M
NCCDPHP CDC HHS U48 DP001903NCCDPHP CDC HHS U48/DP001903
6 · The paper itself

Abstract

introductionBrazil's national strategy for cervical cancer screening includes using the Papanicolaou (Pap) test every 3 years among women aged 25-64 years. Comprehensive primary care services are provided through a network of primary health units, but little is known about cervical cancer-related knowledge, attitudes, and practices among health professionals and coordinators working in these facilities.

methodsIn 2011, we conducted a cross-sectional nationally representative phone survey of 1,600 primary health care units to interview one unit coordinator and one health care professional per unit (either nurse, physician, or community health worker). Responses were obtained from 1,251 coordinators, 182 physicians, 347 nurses, and 273 community health workers. Questionnaires were administered to assess health units' characteristics and capacity for cervical cancer-related services as well as health professionals' perceived effectiveness of the Pap test, preparedness to talk to women about cervical cancer, adherence with screening guidelines, and willingness to recommend human papillomavirus (HPV) vaccination to females.

resultsMost units conducted screening (91.9%), used home visits to conduct recruitment and outreach (83.4%), and provided follow-up to women who did not return to discuss Pap test results (88.1%). Approximately 93% of health professionals stated that Pap testing was effective in decreasing death rates from cervical cancer and 65% stated that national guidelines for cervical cancer screening are very influential; 93% of nurses and physicians reported screening women annually and 75% reported beginning to screen women younger than 25 years old. Regarding HPV vaccination, almost 90% of nurses and physicians would recommend the HPV vaccine to their females patients if it were available. A larger proportion of physicians and nurses recommended the HPV vaccine to older girls (13-18 years) and women (19-26 years and even older than 26 years) than to younger girls (12 years or younger).

conclusionAlthough Brazil's network of primary care units has significantly increased access to cervical cancer screening, effective strategies are needed to ensure that women get screened at the appropriate ages and intervals. Additionally, this study's baseline data on HPV vaccination may be useful as Brazil embarks on a national HPV vaccination program in 2014.

Indexed as

Attitude of Health PersonnelPapanicolaou TestPapillomavirus VaccinesPrimary Health CareAdolescentAdultBrazilCross-Sectional StudiesEarly Detection of CancerFemaleHealth Knowledge, Attitudes, PracticeHealth PersonnelHumansMaleMass ScreeningMiddle AgedPapillomavirus VaccinesCervical cancer knowledgeCervical cancer screening in BrazilGlobal healthHPV vaccination

Identifiers

PMID24668334
PMCPMC3983817

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.